A machine learning-driven eNose detects ovarian cancer in blood plasma with 97 % sensitivity and specificity, offering a promising biomarker-agnostic approach.

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

ClearNote Health's enhanced Avantect Pancreatic Cancer Test features industry-leading detection sensitivity and specificity ...

Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...

A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.

PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...

Affinity leans on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health expands liquid biopsy and screening. Which strategy is ahead? Let's see.

Researchers have developed an electronic nose that can “smell” early signs of ovarian cancer in the blood. The method is precise and could eventually be used to find many different cancers.

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...